Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

SARS-CoV-2 antigen tests used at the point-of-care, such as the Abbott Panbio, have great potential to help combat the COVID-19 pandemic. The Panbio is Health Canada approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of COVID-19 symptom onset(s). Symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, William, Berenger, Byron M., Portnoy, Danielle, Scott, Brittney, Szelewicki, Jonas, Singh, Takshveer, Venner, Allison A., Turnbull, LeeAnn, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Guttridge, Tracy, Proctor, Dustin, Hu, Jia, Tipples, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979467/
https://www.ncbi.nlm.nih.gov/pubmed/33742322
http://dx.doi.org/10.1007/s10096-021-04202-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979467/
https://www.ncbi.nlm.nih.gov/pubmed/33742322
http://dx.doi.org/10.1007/s10096-021-04202-9

Ejemplares similares